Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > NAD for Sale > 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - large image1
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - image1
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - image2
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - image3
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - image4
99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides buy - image5

99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides

126 Inquiries

Unit Price:

$5-6/G FOB

Get Latest Price
CAS No.:

53-84-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

sz

Brand:

DL

Packaging:

1g/2g/3g/4g/5g/6g/7g/8g/9g/10g/1kg/10kg

Sample Available:

Yes

Price valid (until):

2027-01-30

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
Average Lead Time:
2 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Mary

    Whatsapp:+86 152 2772 7503

    Email Address:sales1@xttch.com

    Nicotinamide Adenine Dinucleotide (NAD) is produced by enzymatic process with high purity (> 99%) , mainly used for health supplements, cosmetics, in vitro diagnostic products (IVD), enzymatic reaction and new drug development.

    After water, NAD+ is the most abundant molecule in the body and is necessary for life. NAD+ is a coenzyme — a “helper” molecule that enzymes need to function. Enzymes are a specialized type of protein that make chemical reactions much faster. For example, without enzymes some biological reactions would take 2.3 billion years to finish. Thus, life would likely not exist without enzymes.

    Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

    NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.



       Name   

          NAD+

           CAS RN

    53-84-9

           Solubility

          Dissolved in dimethyl sulfoxide

           Storage condition

          -20°C

           EINECS

            200-001-8


    Appearance: Powder

    Purity: >99% (or refer to the Certificate of Analysis)

    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

    Solubility: To be determined

    Shelf Life: >2 years if stored properly

    Drug Formulation: To be determined

    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    HS Tariff Code: 2934.99.9001

    Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 1 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 2 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 3 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 4 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 5




      Company profile


    Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.


    Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 6 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 7 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 8 Shop 99% Purity 53-84-9 Raw Powder Nad NAD;Tirzepatide,Retatrutide,Peptides-Detailed Image 9


      Why choose us  


    Our company has independent factories, mass production of pharmaceutical intermediates, organic intermediates and other raw materials, widely used in medicine, health care products, cosmetics, nutritional supplements, food additives and other fields.

    Our company adheres to the business philosophy of integrity and cooperation. scientific innovation and service first.With absolute quality assurance as the purpose and perfect service system as the basis, our company provides efficient and satisfactory consulting services, sincerely welcomes your business inquiries,and looks forward to working with you to create a new future.  

    Key Products:
    Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.


      Certificates 



    ECHEMI Editorial Reference
    NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
    Solid
    NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.

    Basic Info
    Product Name:

    NAD

    Other Name:

    Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3

    CAS No.:

    53-84-9

    Molecular Formula:

    C21H27N7O14P2

    InChIKeys:

    InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N

    Molecular Weight:

    663.43

    Exact Mass:

    663.109131

    EC Number:

    200-184-4

    NSC Number:

    757121

    DSSTox ID:

    DTXSID2045236

    NCI Thesaurus Code:

    C87339

    HScode:

    29349990

    Characteristics
    PSA:

    321

    XLogP3:

    -1.29620

    Appearance:

    White Powder

    Melting Point:

    140-142 °C (decomp)

    Water Solubility:

    soluble in water at 50mg/ml

    Storage Conditions:

    2-8°C

    Specific rotation:

    D20 -31.5° (c = 1.2 in water)

    Collision Cross Section:

    226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Not classified.

    GHS label elements, including precautionary statements

    Pictogram(s) No symbol.
    Signal word

    No signal word

    Hazard statement(s)

    none

    Precautionary statement(s)
    Prevention

    none

    Response

    none

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

    Location:

    Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

    Average lead Time:

    2 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Changsha Duole Technology Co., Ltd

    Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.

  • Inquiry History
    126 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    NAD

    1 KG Oct 26, 2026
    India

    NAD

    100 G Oct 21, 2026
    India

    NAD+

    20 G Sep 30, 2026
    United States

    NAD

    30 MT Sep 29, 2026
    United Arab Emirates

    NAD

    10 MT Sep 19, 2026
    Australia

    NAD

    50 PCS Sep 16, 2026
    United States

    NAD

    30 MG Sep 1, 2026
    Philippines

    NAD+

    15 KG Sep 1, 2026
    Philippines

    NAD+

    15 KG Aug 31, 2026
    United Kingdom

    NAD+ 500mg for IV therapy

    2 MG Aug 11, 2026
    United States

    NAD+

    1 G Aug 7, 2026
    United States

    NAD+ 500mg / 1000mg

    100 MG Aug 7, 2026
    United States

    NAD+

    1000 MG Aug 4, 2026
    South Africa

    Nad+

    10 MT Jul 27, 2026
    United States

    β-Nicotinamide adenine dinucleotide

    10 G Jul 16, 2026
    Poland

    Fenbendazole

    1 KG Jul 14, 2026
    United States

    NAD

    10 MT Jul 9, 2026
    United States

    NAD+ 500

    10000 MG Jul 2, 2026
    United States

    Beta-Nicotinamide adenine dinucleotide Nad+

    1 MG Jun 18, 2026
    Australia

    Nad

    10 MG Jun 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.